HERON THERAPEUTICS INC earnings per share and revenue

AXD2 earnings per share for the last quarter are -0.03 EUR whereas the estimation was -0.03 EUR which accounts for 20.79% surprise. Company revenue for the same period amounts to 29.47 M EUR despite the estimated figure of 33.02 M EUR. Estimated earnings per share for the next quarter are -0.03 EUR, and revenue is expected to reach 36.02 M EUR. Also watch annual changes over time to get a bigger picture of AXD2 earnings per share and revenue dynamics.